首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

Frontiers of Medicine
ISSN：2095-0217

Frontiers of Medicine

FRONT MED-PRC
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：-
新锐分区：医学3区
年发文量：66
影响因子：3.5
JCR分区：Q2

基本信息

《医学前沿》是由教育部主办的国际综合性医学期刊。该杂志由高等教育出版社和施普林格联合出版。在线版本可通过www.example.com获得http://link.springer.com/。自2010年第一期以来，该期刊已在PubMed/MEDLINE中编入索引。《医学前沿》致力于发表有关临床和基础医学最新进展的原创研究和评论文章，重点关注流行病学、中医药、转化研究、医疗保健、公共卫生和卫生政策。该杂志采用严格的同行评审和编辑流程，以确保稿件的科学准确性、新奇性和重要性。前沿医学致力于通过与世界各地医疗、疾病预防和科学研究专业人士的交流，更新医学进展，分享疾病控制和治疗经验，并就卫生政策、医疗服务和医疗改革交换意见，促进健康和医疗保健。
2095-0217SCIE/Scopus收录
3.5
点击查看最新影响趋势>
3.9
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
ONCOLOGY 肿瘤学
3区
MEDICINE, GENERAL & INTERNAL 医学：内科
2区
MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验
3区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：MEDICINE, RESEARCH & EXPERIMENTAL
SCIE
Q2
68/195
学科：ONCOLOGY
SCIE
Q2
106/328
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：MEDICINE, RESEARCH & EXPERIMENTAL
SCIE
Q2
70/195
学科：ONCOLOGY
SCIE
Q2
116/328
28
66
点击查看年发文量趋势图>
73%---ONCOLOGYMEDICINE, RESEARCH & EXPERIMENTAL&-MEDICINE, RESEARCH & EXPERIMENTAL
2.9%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
65.15%4.72%1.15%
CiteScore：8.20
SJR：1.254
SNIP：0.977
学科类别分区排名百分位
大类：Medicine
小类：General Medicine
Q1
45 / 668

期刊高被引文献

Management of cytokine release syndrome related to CAR-T cell therapy
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0714-8
The FGF metabolic axis
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0711-y
Monitoring checkpoint inhibitors: predictive biomarkers in immunotherapy
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-018-0678-0
Altered intestinal microbiota associated with colorectal cancer
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0695-7
Cytokines and inflammation in adipogenesis: an updated review
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-018-0625-0
Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0683-y
Survey on deep learning for pulmonary medical imaging
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0726-4
PD-1/PD-L1 blockade in cervical cancer: current studies and perspectives
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-018-0674-4
Compound C620-0696, a new potent inhibitor targeting BPTF, the chromatin-remodeling factor in non-small-cell lung cancer
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0694-8
A reignited debate over the cell(s) of origin for glioblastoma and its clinical implications
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0700-1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0721-9
Immunoregulatory effects of Tripterygium wilfordii Hook F and its extracts in clinical practice
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-018-0649-5
Overexpressed long noncoding RNA CRNDE with distinct alternatively spliced isoforms in multiple cancers
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-017-0557-0
The function and regulation of OTU deubiquitinases
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0734-4
Immunotherapy-based combination strategies for treatment of gastrointestinal cancers: current status and future prospects
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0685-9
Chinmedomics facilitated quality-marker discovery of Sijunzi decoction to treat spleen qi deficiency syndrome
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0705-9
Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-018-0641-0
Structural shifts in the intestinal microbiota of rats treated with cyclosporine A after orthotropic liver transplantation
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-018-0675-3
Homoharringtonine is a safe and effective substitute for anthracyclines in children younger than 2 years old with acute myeloid leukemia
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-018-0658-4
Deciphering the pharmacological mechanism of Guan-Jie-Kang in treating rat adjuvant-induced arthritis using omics analysis
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-018-0676-2
Targeted therapy of desmoid-type fibromatosis: mechanism, current situation, and future prospects
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-018-0672-6
Minimal residual disease-directed immunotherapy for high-risk myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-018-0665-5
Temporal echocardiography findings in patients with fulminant myocarditis: beyond ejection fraction decline
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0713-9
Growth suppression of colorectal cancer expressing S492R EGFR by monoclonal antibody CH12
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0682-z
Expression status of GATA3 and mismatch repair proteins in upper tract urothelial carcinoma
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0687-7
High-affinity T cell receptors redirect cytokine-activated T cells (CAT) to kill cancer cells
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-018-0677-1
Plasma soluble C-type lectin-like receptor-2 is associated with the risk of coronary artery disease
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0692-x
Prevention and treatment of pancreatic fistula after pancreatic body and tail resection: current status and future directions
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0727-3
Identification of an E3 ligase-encoding gene RFWD3 in non-small cell lung cancer
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0708-6
Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl4-induced cirrhotic rats
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0689-5
New spinal robotic technologies
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0716-6
Symptom network topological features predict the effectiveness of herbal treatment for pediatric cough
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0699-3
Acetylated HOXB9 at lysine 27 is of differential diagnostic value in patients with pancreatic ductal adenocarcinoma
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0696-6
Direct acting antiviral-induced dynamic reduction of serum α fetoprotein in hepatitis C patients without hepatocellular carcinoma
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0707-7
Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-018-0639-7
Keratin 5-Cre-driven deletion of Ncstn in an acne inversa-like mouse model leads to a markedly increased IL-36a and Sprr2 expression
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0722-8
Clinical characteristics and prognostic values of 1p32.3 deletion detected through fluorescence in situ hybridization in patients with newly diagnosed multiple myeloma: a single-center study in China
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0712-x
Potential functions of esophageal cancer-related gene-4 in the cardiovascular system
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0701-0
Medical oncology management of advanced hepatocellular carcinoma 2019: a reality check
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0728-2
Screening responsive or resistant biomarkers of immune checkpoint inhibitors based on online databases
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0679-7
Glycosylation of dentin matrix protein 1 is critical for fracture healing via promoting chondrogenesis
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0693-9
Netrin-1 works with UNC5B to regulate angiogenesis in diabetic kidney disease
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0715-7
Presence of multiple abnormal immunologic markers is an independent prognostic factor of diffuse large B-cell lymphoma
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0680-1
Unidirectional and stage-dependent roles of Notch1 in Wnt-responsive Lgr5+ cells during mouse inner ear development
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0703-y
NES1/KLK10 and hNIS gene therapy enhanced iodine-131 internal radiation in PC3 proliferation inhibition
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-018-0643-y
PET imaging on neurofunctional changes after optogenetic stimulation in a rat model of panic disorder
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0704-x
Anti-β2GPI/β2GPI complexes induce platelet activation and promote thrombosis via p38MAPK: a pathway to targeted therapies
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-018-0673-5
Positive stool culture could predict the clinical outcomes of haploidentical hematopoietic stem cell transplantation
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0681-0
Detecting genetic hypermutability of gastrointestinal tumor by using a forensic STR kit
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-019-0698-4
Erratum to: Irreversible phenotypic perturbation and functional impairment of B cells during HIV-1 infection
来源期刊：Frontiers of MedicineDOI：10.1007/s11684-018-0618-z

相关文章

Frontiers of Medicine：中科院2区，内科，研究与实验，肿瘤学，接受率为19%
2025-08-10
Frontiers of Medicine：中科院2区，医学前沿
2025-07-07
Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15

期刊推荐

AAPS Journal封面

AAPS Journal

学科领域：医学
影响因子：3.7
中科院分区： 3区
AAPS PHARMSCITECH封面

AAPS PHARMSCITECH

学科领域：医学
影响因子：4
中科院分区： 3区
Academic Pediatrics封面

Academic Pediatrics

学科领域：医学
影响因子：2.8
中科院分区： 3区
ACTA ANAESTHESIOLOGICA SCANDINAVICA封面

ACTA ANAESTHESIOLOGICA SCANDINAVICA

学科领域：医学
影响因子：2
中科院分区： 3区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学3区
ONCOLOGY 肿瘤学
3区
MEDICINE, GENERAL & INTERNAL 医学：内科
2区
MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验
3区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学2区
MEDICINE, GENERAL & INTERNAL 医学：内科
2区
MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验
2区
ONCOLOGY 肿瘤学
2区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学3区
MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验
3区
ONCOLOGY 肿瘤学
4区
否
否